DEUTSCHE BANK AG\ - AUXILIUM PHARMACEUTICALS INC ownership

AUXILIUM PHARMACEUTICALS INC's ticker is and the CUSIP is 05334DAA5. A total of 36 filers reported holding AUXILIUM PHARMACEUTICALS INC in Q4 2013. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
DEUTSCHE BANK AG\ ownership history of AUXILIUM PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2014$35,457,000
+12.1%
23,898,000
-0.3%
0.02%
+10.0%
Q3 2014$31,623,000
+19.0%
23,980,000
-2.3%
0.02%
+11.1%
Q2 2014$26,567,000
+147494.4%
24,543,000
+144270.6%
0.02%
Q4 2013$18,00017,0000.00%
Other shareholders
AUXILIUM PHARMACEUTICALS INC shareholders Q4 2013
NameSharesValueWeighting ↓
Wellesley Asset Management 22,144$24,659,0001.74%
Baker Brothers Advisors 87,090,000$96,343,0001.36%
SYMPHONY ASSET MANAGEMENT LLC 10,000,000$11,063,0000.81%
WOLVERINE ASSET MANAGEMENT LLC 35,608,000$39,670,0000.78%
Pinnacle Holdings, LLC 2,110,000$2,337,374,0000.68%
Man Investments (CH) AG 1,200,000$1,337,0000.55%
ADVENT CAPITAL MANAGEMENT /DE/ 28,969,000$32,352,0000.41%
Visium Asset Management, LP 13,000,000$14,461,0000.28%
PALISADE CAPITAL MANAGEMENT, LP 7,380,000$8,240,0000.21%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 2,500,000$2,771,0000.14%
View complete list of AUXILIUM PHARMACEUTICALS INC shareholders